Connection

Rita Ryan to Bronchopulmonary Dysplasia

Back to Details
This is a "connection" page, showing publications Rita Ryan has written about Bronchopulmonary Dysplasia.
Rita Ryan
Connection Strength
5.343
Bronchopulmonary Dysplasia
  1. Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia. J Perinatol. 2021 08; 41(8):1783-1796.
    View in: PubMed
    Score: 0.716
  2. Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants. Am J Perinatol. 2020 12; 37(14):1425-1431.
    View in: PubMed
    Score: 0.632
  3. Respiratory Medications in Infants <29?Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. J Pediatr. 2019 05; 208:148-155.e3.
    View in: PubMed
    Score: 0.614
  4. Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. J Pediatr. 2019 04; 207:130-135.e2.
    View in: PubMed
    Score: 0.607
  5. Bronchopulmonary dysplasia: new becomes old again! Pediatr Res. 2017 01; 81(1-2):210-213.
    View in: PubMed
    Score: 0.519
  6. Animal models of bronchopulmonary dysplasia. The preterm and term rabbit models. Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15; 307(12):L959-69.
    View in: PubMed
    Score: 0.453
  7. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol. 2008 Apr; 34(2):174-90.
    View in: PubMed
    Score: 0.288
  8. A new look at bronchopulmonary dysplasia classification. J Perinatol. 2006 Apr; 26(4):207-9.
    View in: PubMed
    Score: 0.251
  9. Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia. Front Immunol. 2020; 11:563473.
    View in: PubMed
    Score: 0.175
  10. Antioxidant MnTBAP does not protect adult mice from neonatal hyperoxic lung injury. Respir Physiol Neurobiol. 2020 11; 282:103545.
    View in: PubMed
    Score: 0.171
  11. Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease. Pediatr Pulmonol. 2020 04; 55(4):899-908.
    View in: PubMed
    Score: 0.163
  12. Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program. Pediatr Pulmonol. 2020 02; 55(2):360-368.
    View in: PubMed
    Score: 0.162
  13. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. J Pediatr. 2018 06; 197:300-308.
    View in: PubMed
    Score: 0.144
  14. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016 Jan; 168:23-29.e4.
    View in: PubMed
    Score: 0.122
  15. Preterm cord blood CD4? T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4? T cells in bronchopulmonary dysplasia. Hum Immunol. 2015 May; 76(5):329-338.
    View in: PubMed
    Score: 0.117
  16. Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome. Am J Perinatol. 2015 Feb; 32(3):225-32.
    View in: PubMed
    Score: 0.111
  17. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007 Jun; 292(6):L1370-84.
    View in: PubMed
    Score: 0.067
  18. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 04; 183:19-25.e2.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.